Afstyla Email: “Consider a twice-weekly therapy that keeps things simple for you”




Brand: Afstyla (antihemophilic factor), Intravenous Infusion
Parent Company: CSL Behring
Drug Type: Prescription
Drug Category: Hematology
Campaign: Launch
Targeting: Patients, Caregivers
Patient Website: https://www.afstyla.com/
HCP Website: https://www.afstyla.com/

Received: Feb 20, 2018 at 7:15 PM

Subject: Consider a twice-weekly therapy that keeps things simple for you

From: CSL Behring Team